Zhihong Chen

Relative Abundance of <i>EGFR</i> Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

Qing Zhou, Xu‐Chao Zhang, Zhihong Chen et al. · Journal of Clinical Oncology · 2011 · 247 citations

Medicine, Oncology, Pharmacology +17

Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma

Lei Yang, Yun-Ting He, Song Dong et al. · Journal for ImmunoTherapy of Cancer · 2022 · 243 citations · Full text

Medicine, Immunology, Oncology +17

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in <i>EGFR/ALK</i> wild-type advanced non-small cell lung cancer

Xiaoxiao Peng, Ruoying Yu, Xue Wu et al. · Journal for ImmunoTherapy of Cancer · 2020 · 186 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Distribution and prognosis of uncommon metastases from non-small cell lung cancer

Feiyu Niu, Qing Zhou, Jin‐Ji Yang et al. · BMC Cancer · 2016 · 165 citations · Full text

Medicine, Oncology, Pathology +13

Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis

Li Sun, Qianqian Wang, Bin Chen et al. · Cell Death and Disease · 2018 · 151 citations · Full text

Medicine, Immunology, Oncology +17